Sarepta Therapeutics, Inc. 4
4 · Sarepta Therapeutics, Inc. · Filed Jun 7, 2013
Insider Transaction Report
Form 4
Christopher Nishan Garabedian
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2013-06-04+185,000→ 185,000 totalExercise: $34.92Exp: 2023-06-04→ Common Stock (185,000 underlying) - Award
Incentive Stock Option (right to buy)
2013-06-04+2,863→ 2,863 totalExercise: $34.92Exp: 2023-06-04→ Common Stock (2,863 underlying) - Award
Non-Qualified Stock Option (right to buy)
2013-06-04+182,137→ 182,137 totalExercise: $34.92Exp: 2023-06-04→ Common Stock (182,137 underlying)
Footnotes (2)
- [F1]This option is exercisable at the rate of 25% of the shares on the first anniversary of the date of grant and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on the fourth anniversary of the date of grant.
- [F2]In the event of the achievement of certain performance milestones prior to January 1, 2017, the shares subject to the option will vest and become exercisable with respect to 1/4th of the total number of shares subject to the option on June 4, 2014 and 1/48th of the original number of shares subject to the option monthly thereafter, subject to continued service with the Issuer.